Cargando…
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
The inflammasome regulates innate immunity by serving as a signaling platform. The Nod-like receptor protein 3 (NLRP3) inflammasome, equipped with NLRP3, the adaptor protein apoptosis-associated speck-like protein (ASC) and pro-caspase-1, is by far the most extensively studied and well-characterized...
Autores principales: | Zhang, Xiaolu, Wang, Ziyu, Zheng, Yujia, Yu, Qun, Zeng, Miao, Bai, Liding, Yang, Lin, Guo, Maojuan, Jiang, Xijuan, Gan, Jiali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049046/ https://www.ncbi.nlm.nih.gov/pubmed/36960868 http://dx.doi.org/10.3892/ijmm.2023.5238 |
Ejemplares similares
-
Interactions between NLRP3 inflammasome and glycolysis in macrophages: New insights into chronic inflammation pathogenesis
por: Yu, Qun, et al.
Publicado: (2021) -
NLRP3 inflammasome as a novel therapeutic target for heart failure
por: Wang, Shuangcui, et al.
Publicado: (2021) -
Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review)
por: Zhang, Xiaolu, et al.
Publicado: (2022) -
Therapeutic Candidates for Alzheimer’s Disease: Saponins
por: Zhang, Ruifeng, et al.
Publicado: (2023) -
Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ
por: Gan, Jiali, et al.
Publicado: (2023)